Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient [2]

Transplantation

Volumn 77, Issue 3, 2004, Pages 479-480

  Mahe, Emmanuel ^a   Bodemer, Christine ^a   Dupic, Laurent ^a   Hubert, Philippe ^a   Lacaille, Florence ^a   Goulet, Olivier ^a   Leruez Ville, Marianne ^a   Fraitag, Sylvie ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZATHIOPRINE; DNA; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LIVER ENZYME; METHYLPREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS; VANCOMYCIN;

CASE REPORT; CHILD; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EPSTEIN BARR VIRUS; GENE; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; LETTER; LEUKOENCEPHALOPATHY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SHORT BOWEL SYNDROME; VIRUS INFECTION;

CHILD; DRUG RESISTANCE; EOSINOPHILIA; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; MALE; SYNDROME; TACROLIMUS;

EID: 1142298444     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000102459.25647.C6     Document Type: Letter

References (5)

1. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272.
2. Descamps V, Bouscarat F, Laglenne S, et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997; 137: 605.
3. Suzuki Y, Inagi R, Aono T, et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998; 134: 1108.
4. Tohyama M, Yahata Y, Yasukawa M, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134: 1113.
5. Descamps V, Mahé E, Houhou N, et al. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus. Br J Dermatol 2003; 148: 1032.